PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
Public ClinicalTrials.gov record NCT00226005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of PTK787/ZK222584 in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Who Failed First-Line Gemcitabine Therapy.
Study identification
- NCT ID
- NCT00226005
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pancreatic Cancer Research Team
- Other
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- PTK787/ZK222584 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- Nov 30, 2008
- Completion
- Jan 31, 2010
- Last update posted
- May 8, 2012
2005 – 2010
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Healthcare | Scottsdale | Arizona | 85259 | — |
| University of Arizona/Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Tower Hematology Oncology Medical Group | Beverly Hills | California | 90211-18500 | — |
| Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins | Baltimore | Maryland | 21231 | — |
| Virginia Piper Cancer Institute/Abbott Northwestern Hospital | Minneapolis | Minnesota | 55407 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| South Texas Oncology and Hematology | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00226005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2012 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00226005 live on ClinicalTrials.gov.